id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-E-0249-0007,FDA,FDA-2022-E-0249,Letter from U. S. Patent and Trademark Office,Other,Letter(s),2024-03-06T05:00:00Z,2024,3,2024-03-06T05:00:00Z,,2024-03-06T18:43:15Z,,0,0,09000064863ef707
FDA-2022-E-0249-0006,FDA,FDA-2022-E-0249,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2024-01-18T05:00:00Z,2024,1,2024-01-18T05:00:00Z,,2024-01-18T21:30:19Z,,0,0,09000064863a950d